CNS Pharmaceuticals Inc. CNSP
Last Post: 12/05/2024 3:09:09 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 3
Post
Subject
Author
Posted On
Recent Articles
- Discover THREE's Innovative Skincare Breakthroughs Today!
- Novo Nordisk's Strategic Acquisition of Catalent's Manufacturing Assets
- Catalent and Novo Holdings Set to Finalize Major Deal Soon
- Opportunity for Wolfspeed Investors to Pursue Class Action
- Kyverna Therapeutics Investors Alert Over Recent Class Action
- Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
- Urgent Alert for Symbotic Investors Regarding Class Action
- Investors Reminded of Key Deadline in PACS Group Lawsuits
- Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
- Important Update for Rentokil Investors on Class Action Lawsuit
- Important Update for Match Group Investors: Legal Actions Ahead
- Investors Urged to Act in Zeta Global Class Action Case
- Celsius Holdings Investors: Important Litigation Updates
- ASML Holding Class Action: Important Update for Investors
- Deadline Approaches for Hasbro Shareholders in Class Action
- Critical Update for Toronto-Dominion Bank Investors in Class Action
- Investors of Kyverna Therapeutics Can Pursue Class Action
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement